4
Changes in Ownership
TEVA PHARMACEUTICAL INDUSTRIES LTD Filed Acc 0001209191-21-018530
President and CEO acquired 59,701 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Schultz Kare · President and CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-03-04 | Exercise or conversion : show line 1 in the form | +59,701 | 860,582 | D |
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-03-04 | Exercise or conversion : show line 2 in the form Restricted Share Units | −59,701 | 119,403 | D |
| 2021-03-05 | Grant or award : show line 3 in the form Restricted Share Units | +285,171 | 285,171 | D |
Loading xslF345X03/doc4.xml…